SEC 13F Intelligence

Boxer Capital, LLC / 698

Boxer Capital, LLC’s Achilles Therapeutics Ads Position

Does Boxer Capital, LLC own Achilles Therapeutics Ads (698)? Not currently — the last reported position was 1.54M shares worth $12M in Q3 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$12M
Q3 2021
Shares
1.54M
% of Portfolio
+0.42%
Quarters Held
3
position exited

Position History 698

Reported value by quarter
Q1 ’21: $25MQ1 ’21Q2 ’21: $15MQ2 ’21Q3 ’21: $12MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.54M$12M+0.42%
Q2 20211.54M$15M+0.53%
Q1 20211.54M$25M+0.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of 698.